HCPCS Level II code L8686 designates an implantable neurostimulator pulse generator, single array, non-rechargeable, including extension. This code identifies a permanently implanted device used to deliver targeted electrical stimulation for neurological conditions, and it matters nationally because implantable neurostimulators are increasingly used across chronic pain and neuromodulation therapies, with implications for device coverage, coding consistency, and utilization oversight.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how L8686 is used in claims, typical sites of service (hospital inpatient/outpatient and ambulatory surgical centers), and clinical context for device implantation. The publication outlines common billing modifiers and related service-line considerations, and provides benchmarks and policy-relevant summaries where available.

This summary equips billing managers, compliance officers, and policy analysts with a concise reference to the code’s clinical role, payer landscape, and the types of documentation and coding scenarios that commonly accompany implantable neurostimulator device claims. Data not available in the input will be noted where applicable.